chr12-49054680-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003482.4(KMT2D):​c.248G>A​(p.Arg83Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 1,612,688 control chromosomes in the GnomAD database, including 733 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 73 hom., cov: 32)
Exomes 𝑓: 0.027 ( 660 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12O:1

Conservation

PhyloP100: 0.648

Publications

21 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00251621).
BP6
Variant 12-49054680-C-T is Benign according to our data. Variant chr12-49054680-C-T is described in ClinVar as Benign. ClinVar VariationId is 94203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0242 (3680/152244) while in subpopulation NFE AF = 0.0344 (2338/68006). AF 95% confidence interval is 0.0332. There are 73 homozygotes in GnomAd4. There are 1820 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3680 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
NM_003482.4
MANE Select
c.248G>Ap.Arg83Gln
missense
Exon 4 of 55NP_003473.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
ENST00000301067.12
TSL:5 MANE Select
c.248G>Ap.Arg83Gln
missense
Exon 4 of 55ENSP00000301067.7
KMT2D
ENST00000683543.2
c.248G>Ap.Arg83Gln
missense
Exon 4 of 56ENSP00000506726.1
KMT2D
ENST00000685166.1
c.248G>Ap.Arg83Gln
missense
Exon 3 of 54ENSP00000509386.1

Frequencies

GnomAD3 genomes
AF:
0.0242
AC:
3682
AN:
152126
Hom.:
73
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00447
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0209
Gnomad ASJ
AF:
0.0236
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0215
Gnomad FIN
AF:
0.0542
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0344
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.0259
AC:
6318
AN:
243934
AF XY:
0.0264
show subpopulations
Gnomad AFR exome
AF:
0.00421
Gnomad AMR exome
AF:
0.0165
Gnomad ASJ exome
AF:
0.0211
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.0479
Gnomad NFE exome
AF:
0.0324
Gnomad OTH exome
AF:
0.0292
GnomAD4 exome
AF:
0.0275
AC:
40154
AN:
1460444
Hom.:
660
Cov.:
33
AF XY:
0.0275
AC XY:
19942
AN XY:
726442
show subpopulations
African (AFR)
AF:
0.00389
AC:
130
AN:
33452
American (AMR)
AF:
0.0169
AC:
752
AN:
44496
Ashkenazi Jewish (ASJ)
AF:
0.0221
AC:
576
AN:
26104
East Asian (EAS)
AF:
0.000177
AC:
7
AN:
39632
South Asian (SAS)
AF:
0.0250
AC:
2155
AN:
86128
European-Finnish (FIN)
AF:
0.0465
AC:
2479
AN:
53304
Middle Eastern (MID)
AF:
0.0239
AC:
138
AN:
5768
European-Non Finnish (NFE)
AF:
0.0291
AC:
32362
AN:
1111258
Other (OTH)
AF:
0.0258
AC:
1555
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2402
4804
7207
9609
12011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1134
2268
3402
4536
5670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0242
AC:
3680
AN:
152244
Hom.:
73
Cov.:
32
AF XY:
0.0244
AC XY:
1820
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00445
AC:
185
AN:
41546
American (AMR)
AF:
0.0209
AC:
320
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0236
AC:
82
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.0215
AC:
104
AN:
4828
European-Finnish (FIN)
AF:
0.0542
AC:
574
AN:
10600
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0344
AC:
2338
AN:
68006
Other (OTH)
AF:
0.0223
AC:
47
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
186
372
557
743
929
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0294
Hom.:
249
Bravo
AF:
0.0196
TwinsUK
AF:
0.0259
AC:
96
ALSPAC
AF:
0.0288
AC:
111
ESP6500AA
AF:
0.00554
AC:
22
ESP6500EA
AF:
0.0309
AC:
256
ExAC
AF:
0.0258
AC:
3119
Asia WGS
AF:
0.0120
AC:
40
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7Other:1
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 20, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jul 06, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Dec 31, 2014
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:4
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D: BP4, BS1, BS2

Nov 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Kabuki syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.039
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.20
N
PhyloP100
0.65
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.70
N
REVEL
Benign
0.26
Sift
Benign
0.38
T
Polyphen
0.0040
B
Vest4
0.074
MPC
0.21
ClinPred
0.0043
T
GERP RS
3.3
Varity_R
0.039
gMVP
0.39
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55865069; hg19: chr12-49448463; COSMIC: COSV56410163; API